Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28,012 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial.
Liu Q, Chen J, Lin Y, Ye J, Shen W, Luo H, Li B, Huang W, Wei S, Song J, Wang Y, Yang H, Lai S, Zhu H, Ai D, Chen Y, Deng J, Hao S, Zhao K. Liu Q, et al. Among authors: zhu h. Lancet Gastroenterol Hepatol. 2024 Jan;9(1):45-55. doi: 10.1016/S2468-1253(23)00316-3. Epub 2023 Nov 18. Lancet Gastroenterol Hepatol. 2024. PMID: 37980921 Clinical Trial.
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H, Rivin Del Campo E, Ye J, Simone CB 2nd, Zhu Z, Zhao W, Amini A, Zhou J, Wu C, Tang H, Fan M, Li L, Lin Q, Xia Y, Li Y, Li J, Mo M, Jia H, Lu S, Wang J, Nie Y, Chen J, Wu S, Hamaji M, Haque W, Jeong BK, Shridhar R, Zhang Z, Chen Y, Zhao K. Zhu H, et al. Among authors: zhu z. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1396-1406. doi: 10.1016/j.ijrobp.2021.02.053. Epub 2021 Mar 5. Int J Radiat Oncol Biol Phys. 2021. PMID: 33677048 Clinical Trial.
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12).
Zhu H, Liu Q, Xu H, Mo M, Wang Z, Lu K, Zhou J, Chen J, Zheng X, Ye J, Ge X, Luo H, Liu Q, Deng J, Ai D, Hao S, Zhang J, Tseng IH, Song S, Chen Y, Zhao K. Zhu H, et al. Radiat Oncol. 2022 Jul 29;17(1):134. doi: 10.1186/s13014-022-02099-y. Radiat Oncol. 2022. PMID: 35906623 Free PMC article. Clinical Trial.
28,012 results
You have reached the last available page of results. Please see the User Guide for more information.